TAVR Medical Device Supply

The contract entails the supply of a fully compliant, FDA-cleared Transcatheter Aortic Valve Replacement (TAVR) device optimized for use across Department of Veterans Affairs healthcare facilities. The device must meet all current regulatory requirements, including adherence to FDA clearance standards, proper labeling, and end-to-end traceability to ensure patient safety and regulatory compliance. It is intended for deployment within VA medical centers and must support clinical workflows with documented reliability and performance consistent with federal healthcare guidelines. This subcontract, posted on July 6, 2026, falls under NAICS code 339113 for Surgical and Medical Instrument Manufacturing and is managed by the Network Contract Office 23 under the Department of Veterans Affairs. The contract does not specify a set-aside classification or a designated place of performance, indicating that the device will be distributed to VA facilities nationwide. All deliverables must align with VA procurement protocols, and suppliers are expected to ensure uninterrupted availability, full regulatory documentation, and compatibility with VA inventory and reporting systems.